NPI registry status
Active
2026 NPPES data Pulmonary Disease Physician NPI 1588692891 M.D.
Verify on CMS → Michael Milam, M.D.
Pulmonary Disease Physician in Lynchburg, Virginia.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 9,647 in Pulmonary Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
1K
Medicare Part D claims · 311 beneficiaries · Pulmonary Disease Physician avg: 1K
Generic prescribing
42%
generic claims · 58% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
89.3/100
▲ 6 pts above national avg 83.5 · Exceptional
Industry payments
$731.26
31 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Michael Milam, M.D. reported a CMS MIPS final score of 89.3/100 - above the 83.5 national average - and filed 1,267 Medicare Part D claims in 2024.
- 89.3/100
- MIPS score · +6 vs avg
- 1K
- Part D claims, 2024
- 42%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Michael Milam, M.D.
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1588692891), first enumerated 06/28/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 1,267 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 89.3/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Industry payment transparency
$731.26 in reported industry payments (31 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1588692891 · Pulmonary Disease Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-ABOVE · RX-MID · BOOK-THIN · PHOTO-FINISH
- NPI-10 1588692891
- ENUM-LEGACY 2006
- TAX-MID 10K Pulmonary Disease
- MIPS-ABOVE 89.3/100
- RX-MID 1,267
- BOOK-THIN 238 in Virginia
- PHOTO-FINISH Fadi Adra · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Milam · this pro…
Milam · this provider
89.3 MIPS pts
- Fadi Adra · high…
Fadi Adra
89.3 MIPS pts
- Lewis Rubinson ·…
Lewis Rubinson
89.3 MIPS pts
- Alan Schwartz · …
Alan Schwartz
89.3 MIPS pts
- Eileen Zhuang · …
Eileen Zhuang
89.3 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Michael Milam, M.D.'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
89 ≥ 56th percentile 56% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Michael Milam, M.D. sits
This provider among pulmonary disease physician peers
Across the 2,467 pulmonary disease physician providers who report both Medicare Part D prescribing and a MIPS quality score, Michael Milam, M.D. writes more Part D claims than 57% of them and scores higher on MIPS quality than 57% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one pulmonary disease physician peer from a representative sample of 60; the gold marker is Michael Milam, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Michael Milam, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Michael Milam, M.D.?
High performer (top quartile)Primary specialty
Pulmonary Disease Physician
Medicare Part D claims
1,267 15% vs specialty avg
MIPS final score
89.3/100 5.8 pts vs avg
Specialty distribution in Virginia
How Pulmonary Disease Physician compares to other specialties among Virginia providers
Medicare quality performance, MIPS
Michael Milam, M.D.'s 2023 MIPS final score plotted against the Pulmonary Disease Physician national average
- MIPS Final Score
- 89.3/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1588692891 |
|---|---|
| Specialty | Pulmonary Disease Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 06/28/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
89.2655
Final Score
Measured-score avg: 83.5
87.3712
Quality
Reporting: Group practice
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Michael Milam, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$731
Largest payer
AstraZeneca Pharmaceuticals LP
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Brand-heavy
Michael Milam, M.D. - brand share 58.0%
Pulmonary Disease Physician average
58% brand-name claims vs 42% generic, on 1,267 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
1,267
Total Claims
$931K
Total Drug Cost
311
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 2,108.033
- Total Day Supply
- 60,286
- Brand vs Generic
- 58% brand / 42% generic
- Brand Drug Cost
- $917K
- Generic Drug Cost
- $15K
- Antibiotic Claims
- 39
Patient Demographics
- Average Patient Age
- 72.6 years
- Avg HCC Risk Score
- 1.77
- Gender Split
- 59% female / 41% male
- Age Distribution
- <65: 49, 65-74: 131, 75-84: 98, 85+: 33
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Michael Milam, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Trelegy Ellipta
Trelegy Ellipta
249 claims
- Albuterol Sulfate …
Albuterol Sulfate Hfa
143 claims
- Breo Ellipta
Breo Ellipta
104 claims
- Prednisone 87
Prednisone
87 claims
- Montelukast Sodium 50
Montelukast Sodium
50 claims
- Fluticasone Propio… 43
Fluticasone Propionate
43 claims
- Anoro Ellipta 35
Anoro Ellipta
35 claims
- Spiriva Respimat 27
Spiriva Respimat
27 claims
| Drug | Claims |
|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 249 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 143 |
| Breo Ellipta Fluticasone/Vilanterol | 104 |
| Prednisone | 87 |
| Montelukast Sodium | 50 |
| Fluticasone Propionate | 43 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 35 |
| Spiriva Respimat Tiotropium Bromide | 27 |
| Roflumilast | 26 |
| Ropinirole Hcl | 24 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pulmonary Disease Physician Overview
How Michael Milam, M.D. fits within the Pulmonary Disease Physician landscape nationally.
9,647
Pulmonary Disease Physician Providers in US
53
States with Pulmonary Disease Physician
1,498
Avg Claims per Provider
Michael Milam, M.D.'s 1,267 claims are below the specialty average of 1,498.
Nationwide Pulmonary Disease Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Milam, both outside Virginia so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (89.3 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Pulmonary Disease Physician Providers in Virginia
Other clinicians with the same primary specialty enrolled in Virginia, drawn from the same CMS NPPES roster as Milam.
One of 238 Pulmonary Disease Physician providers enrolled in Virginia, 5 are shown here.
Dr. Nathalie Abi Hatem
M.D.
Salem, VA
Dr. Youssef Abouleish
MD
Suffolk, VA
Dr. Jawed Abubaker
MD
Petersburg, VA
Dr. Richard Ackart
MD
Williamsburg, VA
Choi Mei Adams
FNP
Charlottesville, VA
Compare Pulmonary Disease Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Michael Milam, M.D.'s specialty? ▼
Michael Milam, M.D. specializes in Pulmonary Disease Physician and practices in Lynchburg, Virginia. Credentials: M.D..
How much does Michael Milam, M.D. prescribe under Medicare Part D? ▼
In 2024, Michael Milam, M.D. wrote 1,267 Medicare Part D claims totaling $931K in drug costs for 311 beneficiaries.
What is Michael Milam, M.D.'s Medicare quality score? ▼
Michael Milam, M.D. has a CMS MIPS Final Score of 89.3/100 (Quality: 87.4). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Michael Milam, M.D. located? ▼
Michael Milam, M.D. is located at 2011 TATE SPRINGS RD, Lynchburg, VA, 24501. Phone: (434) 947-3963.
What is Michael Milam, M.D.'s NPI number? ▼
Michael Milam, M.D.'s National Provider Identifier (NPI) is 1588692891, issued on 06/28/2006.
Does Michael Milam, M.D. prescribe more brand-name or generic drugs? ▼
Michael Milam, M.D.'s prescribing is 58% brand-name and 42% generic drugs by claim count, with $917K in brand drug costs.
How many Pulmonary Disease Physician providers are there in the US? ▼
There are 9,647 Pulmonary Disease Physician providers across 53 states in the US. The average Pulmonary Disease Physician provider writes 1,498 Medicare Part D claims per year.
What drugs does Michael Milam, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Michael Milam, M.D.'s most frequently prescribed drugs include Trelegy Ellipta, Albuterol Sulfate Hfa, Breo Ellipta. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Michael Milam, M.D. accept Medicare? ▼
Michael Milam, M.D. appears in CMS Medicare data with 1,267 Part D claims and 311 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Michael Milam, M.D.'s credentials? ▼
Michael Milam, M.D.'s NPI is 1588692891 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.